Hydroxychloroquine 2028 by Type, and Application | The Insight Partners

report image

Hydroxychloroquine Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Type (USP Standards Grade, EP Standards Grade, Pharmaceutical Standards Grade, Others); Application (Uncomplicated malaria, Rheumatoid arthritis, Chronic discoid lupus erythematosus, Systemic lupus erythematosus, Others)

Report Code: TIPRE00010197 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Hydroxychloroquine is a medicinal drug that is used to prevent or treat malaria caused by mosquito bites. Mainly this drug is known for malaria, but it is also used in the treatment of systemic lupus erythematosus, rheumatic disorders like rheumatoid arthritis, and Q fever. Its alternative name is Hydroxychloroquine sulfate. Recently, Hydroxychloroquine (Plaquenil) and its sister drug chloroquine (Aralen) are under investigation for the treatment of the COVID-19 coronavirus disease.


The hydroxychloroquine market is anticipated to grow due to the increasing prevalence of chronic diseases worldwide. However, the drug has some side effects like headache, drowsiness, visual disturbances, cardiovascular collapse, convulsions, hypokalemia, rhythm and conduction disorders including QT prolongation, ventricular tachycardia, and ventricular fibrillation can restrain the market. Moreover, there is a constant need for Hydroxychloroquine in treating this disease, making the market less vulnerable to outside changes. Whereas, recent positive research on the treatment of novel coronavirus using Hydroxychloroquine came up with positive signs, which is helping in the growing demand of this drug from the last one month that is expected to drive the market in the forecast period.


The “Hydroxychloroquine Market Analysis to 2028” is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in hydroxychloroquine market with detailed market segmentation by type, and application. The hydroxychloroquine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in hydroxychloroquine market and offers key trends and opportunities in the market.


The hydroxychloroquine market is segmented on the basis of type, and application. Based on type, the market is segmented as USP standards grade, EP standards grade, pharmaceutical standards grade and others. On the basis of application, the market is categorized into uncomplicated malaria, rheumatoid arthritis, chronic discoid lupus erythematosus, systemic lupus erythematosus and others.

Get more information on this report :


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the hydroxychloroquine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hydroxychloroquine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting hydroxychloroquine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hydroxychloroquine market in these regions.

Get more information on this report :


The report covers key developments in the hydroxychloroquine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players in hydroxychloroquine market are anticipated to have lucrative growth opportunities in the future with the rising demand for  hydroxychloroquine in the global market. Below mentioned is the list of few companies engaged in the hydroxychloroquine market.

The report also includes the profiles of key companies in hydroxychloroquine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  • Cadila Healthcare Ltd
  • Hikma Pharmaceuticals PLC
  • Ipca Laboratories Ltd.
  • Mylan N.V.
  • Novartis AG
  • Sanofi S.A.
  • Shanghai Pharmaceuticals Holding Co., Ltd
  • Taj Pharmaceuticals Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Ltd.

The Insight Partner’s dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Get more information on this report :

The List of Companies

  1. Cadila Healthcare Ltd
  2. Hikma Pharmaceuticals PLC
  3. Ipca Laboratories Ltd.
  4. Mylan N.V.
  5. Novartis AG
  6. Sanofi S.A.
  7. Shanghai Pharmaceuticals Holding Co., Ltd
  8. Taj Pharmaceuticals Ltd.
  9. Teva Pharmaceutical Industries Ltd.
  10. Torrent Pharmaceuticals Ltd.
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount